The role of early magnetic resonance imaging in predicting survival on bevacizumab for recurrent glioblastoma: Results from a prospective clinical trial (CABARET)
Kathryn M Field, Pramit M Phal, Greg Fitt, Christine Goh, Anna K Nowak, Mark A Rosenthal, John Simes, Elizabeth H Barnes, Kate Sawkins, Lawrence M Cher, Elizabeth J Hovey, Helen Wheeler
Cancer | WILEY | Published : 2017
Awarded by National Health and Medical Research Council
This was an investigator-driven study funded by Roche Products Pty Limited (Australia) and the National Health and Medical Research Council (grant 1037786). Funding was also received from Cancer Council New South Wales for translational research substudies conducted for this trial. Kathryn M Field was supported by a Stella Mary Langford Scholarship (University of Melbourne), the Royal Melbourne Hospital Research Medal, and the Watt-Geyer Memorial Research Fund.